Novel Pharmacological and Nanotechnology-Based Therapeutic Strategies for MASLD.

Pharmaceutics · 2026 · PMC13210413 · PMID 42198278

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In a phase 2 trial, semaglutide led to NASH resolution in 59% of patients, compared with 17% with placebo, although fibrosis improvement did not reach statistical significance [ 18 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.